University of North Carolina at Chapel Hill
ORCID: 0000-0002-2501-720XAlso affiliated with UNC Lineberger Comprehensive Cancer Center
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: “Phase II single-arm study of palbociclib and cetuximab in anti-EGFR naïve patients with KRAS/NRAS/BRAF wild-type, metastatic colorectal cancer”.
Dominic T. Moore, Matthew J. Reilley, Mohamed E. Salem, Tammy Triglianos, Autumn J McRee +4 more